
Keywords: CVID; common variable immunodeficiency; ESID; European Society for Immunodeficiencies; HI; hemagglutination inhibition; PBMCs; peripheral blood mononuclear cells; PID; primary immunodeficiency disorder; RRTI; recurrent respiratory tract infections; uAD; u